北京天坛医院品牌怎么样 申请店铺

我要投票 北京天坛医院在男科医院行业中的票数:275 更新时间:2025-06-28
北京天坛医院是哪个国家的品牌?「北京天坛医院」是首都医科大学附属北京天坛医院旗下著名品牌。该品牌发源于北京市,由创始人王院长在1956年期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力北京天坛医院品牌出海!将品牌入驻外推网,定制北京天坛医院品牌推广信息,可以显著提高北京天坛医院产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

北京天坛医院怎么样


首都医科大学附属北京天坛医院始建于1956年8月23日,是一所以神经外科为先导,神经科学为特色,集医、教、研、防为一体的三级甲等综合性医院。是世界三大神经外科研究中心之一、亚洲的神经外科临床、科研、教学基地。医院总占地面积83900.56平方米,建筑面积 92898.56平方米,编制床位950张,临床、医技科室45个,全院职工总数2787人。年门急诊量约140余万人次,年住院病人约3万人次,年手术量2万余例次。

北京市神经外科研究所、国家神经系统疾病临床医学研究中心、北京市伽玛刀治疗研究中心、北京市脑血管病抢救治疗中心、国家脑血管病创新药物临床评价技术平台、WHO在中国的神经科学培训合作中心、北京脑重大疾病研究院脑卒中研究所、北京脑重大疾病研究院脑肿瘤研究所、北京神外学院、首都医科大学第五临床医学院、全国脑血管病防治办公室、北京市脑血管病临床研究中心、北京市脑血管病防治指导办公室、中国卒中培训项目以及《中华神经外科杂志》、《中国卒中杂志》等一批机构设在我院。

功能神经外科和清华大学联合被授予神经调控工程中心称号;我院的脑血管病中心是北京市脑血管病临床研究中心和国家“十二五”重大新药创制脑血管病临床评价的依托平台;赵继宗教授获得了“2012年Walter E. Dandy神经外科学会荣誉奖”;戴建平教授入选美国科学院2012年新一批外籍院士,成为继巴德年、陈竺、韩启德之后又一来自中国的该院外籍院士;王拥军副院长获得 2012年首都危险疾病科技成果推广专项和北京市科技惠民奖,主编了2012 年卫生部颁布的《缺血性脑卒中诊断和诊疗质量控制》。

2013年12月19日赵继宗教授当选为中国科学院院士。

我院作为北京市医改第三批试点医院,实施了医药分开试点工作,深入推动了医院管理体制机制变革。开展电子病历、临床路径、DRGs付费、缩短平均住院日、抗菌药物监管治理、加强危急值的管理、处方点评、加强床位管理、优质护理服务等方面的工作。

我院承担了西藏自治区、新疆维吾尔自治区和内蒙古自治区所辖5所医院,以及东城区和丰台区的五所医院的对口支援任务。

医院全体职工在医院党委和领导班子的带领下,发扬王忠诚院士开拓创新、团结协作、严谨求实、艰苦奋斗、病人优先的精神,推动我国神经科学事业向更高水平发展。以“全心全意为病人服务”为宗旨,推进服务质量和医疗质量管理为核心的医疗管理体系;提升学科和人才队伍建设水平,培养更多热爱医院、有才华的专业和管理年轻人才;继续实施绩效管理,创建以绩效考核为核心的人力资源管理体系;完善各项管理监督机制,创建以成本核算为核心的后勤管理体系;推进新院迁建工作尽早进入建设阶段,推动天坛医院实现新的历史跨越,让天坛品牌永葆辉煌。


Beijing Tiantan Hospital, affiliated to Capital Medical University, was founded on August 23, 1956. It is a third-class comprehensive hospital with neurosurgery as the guide and neuroscience as the feature, integrating medicine, teaching, research and prevention. It is one of the three neurosurgery research centers in the world and the clinical, scientific and teaching base of neurosurgery in Asia. The hospital covers an area of 83900.56 square meters, with a building area of 92898.56 square meters. It has 950 beds, 45 clinical and medical technology departments, and 2787 employees. The annual outpatient and emergency treatment volume is about 1.4 million person times, the annual inpatient volume is about 30000 person times, and the annual operation volume is more than 20000. Beijing neurosurgery Research Institute, National Clinical Medicine Research Center for nervous system diseases, Beijing gamma knife treatment research center, Beijing cerebrovascular disease rescue and treatment center, national cerebrovascular disease innovative drug clinical evaluation technology platform, who China neuroscience training cooperation center, stroke research institute of Beijing Institute of major brain diseases, Beijing major brain disease research center The Institute of brain tumor research, Beijing Shenwai college, the fifth Clinical Medical College of Capital Medical University, the National Office of cerebrovascular disease prevention and control, Beijing clinical research center of cerebrovascular disease, Beijing cerebrovascular disease prevention and control guidance office, China stroke training program, China Journal of Neurosurgery, China stroke journal and other institutions are located in our hospital. Functional neurosurgery and Tsinghua University were jointly awarded the title of neuroregulation Engineering Center; the cerebrovascular disease center of our hospital is the supporting platform for clinical evaluation of Beijing cerebrovascular disease clinical research center and national "12th Five Year Plan" major new drug creation cerebrovascular disease; Professor Zhao Jizong won the "2012 Walter E. dandy neurosurgery society honorary Award"; Professor Dai Jianping was selected into American Science In 2012, a new group of foreign academicians of the Academy became another foreign academician from China after badian, Chen Zhu and Han Qide. Wang Yongjun, vice president of the Academy, won the special promotion project of scientific and technological achievements of dangerous diseases in the capital in 2012 and the Beijing Science and Technology Award for the benefit of the people, and edited the diagnosis and treatment quality control of ischemic stroke issued by the Ministry of health in 2012. On December 19, 2013, Professor Zhao Jizong was elected as an academician of the Chinese Academy of Sciences. As the third batch of pilot hospitals of Beijing medical reform, our hospital has carried out the pilot work of separating medicine and further promoted the reform of hospital management system and mechanism. Carry out the work of electronic medical record, clinical pathway, DRGs payment, shortening the average length of stay, antimicrobial drug supervision and management, strengthening the management of critical value, prescription review, strengthening bed management, quality nursing services, etc. Our hospital has undertaken the counterpart support tasks of five hospitals under the jurisdiction of Tibet Autonomous Region, Xinjiang Uygur Autonomous Region and Inner Mongolia Autonomous Region, as well as five hospitals in Dongcheng District and Fengtai District. Under the leadership of the hospital Party committee and the leading group, all staff of the hospital carry forward the spirit of Academician Wang Zhongli's pioneering innovation, unity and cooperation, rigorous and realistic, hard work and patient priority, and promote the development of neuroscience in China to a higher level. With the purpose of "serving patients wholeheartedly", promote the medical management system with service quality and medical quality management as the core; improve the level of discipline and talent team construction, cultivate more professional and management young talents who love hospitals and have talent; continue to implement performance management, create a human resource management system with performance assessment as the core; improve various management and supervision mechanisms To establish a logistics management system with cost accounting as the core; to promote the relocation of the new hospital to enter the construction stage as early as possible, to promote the Tiantan Hospital to achieve a new historical leap, so that the brand of Tiantan will remain brilliant forever.

本文链接: https://brand.waitui.com/5984c1b65.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

业内称部分显卡租赁价格较年初高点“腰斩”

记者多方采访获悉,当前算力租赁市场处于阶段性低迷期,以H20为代表的显卡租赁价格相较年初高点已“腰斩”,多位受访者坦言“现在算力市场比较难做”、“红利期过了”。同时,针对近期宝德、思腾合力欲“卖身”A股上市公司、莲花控股为盘活资产出售智算服务器等业内消息,从业者称由于AI芯片技术门槛不断提高,叠加芯片原厂通过“捆绑销售”等方式降低了AI服务器厂商的议价权、选择权,导致市场形势日渐紧迫,大部分厂商最终或难逃组装厂的命运。(财联社)

59分钟前

沪市公司2024年现金分红达1.8万亿,创历史新高

上海证券交易所副总经理王泊6月28日在2025上市公司论坛上表示,沪市公司2024年现金分红达1.8万亿,创历史新高,分红比例达35.6%,约500家次公司推出中期分红,满足投资者现金流需求。近三年,有68家公司累计现金分红超百亿;872家公司连续三年分红比例超过30%;199家公司连续三年分红比例超过50%。(财联社)

59分钟前

比亚迪或于7月1日起在全国范围取消限时“一口价”政策

6月28日,网上流传比亚迪即将启动新购车政策的图片,显示7月1日起此前报价方案、政策将全部作废。对此,比亚迪未正式回应,但北京某比亚迪海洋网门店销售员证实图片内容为真,并表示7月会有新销售政策。另一位王朝网销售员也指出,7月1日起购车政策大调整。(每日经济新闻)

59分钟前

云深处融资总监陈贞豪:公司今年出货量比往年高很多,B端市场未来可达几百亿

在2025华映资本年度大会上,具身智能企业云深处科技的融资总监陈贞豪在接受采访时表示,公司今年出货量比往年高很多,“肯定能达到几千台”,能实现盈利,大B端(企业端)的流量有望为公司带来长期红利:“今年的这波红利让全国各地的新兴行业都主动找到我们对接。其中很多可以转化成很好的商业机会。我们预测其中很多新增场景未来每年可能带来几十亿的市场空间,那么我们的几个B端市场也能组成几百亿的市场空间。”(澎湃新闻)

59分钟前

23只新型浮动费率基金成立,总规模超218亿元

根据wind数据统计,截至6月28日,全市场首批26只新型浮动费率基金已有23只成立,总共募集规模约为218.25亿元。其中有7只基金募集规模超过10亿元。(证券时报)

59分钟前

本页详细列出关于北京天坛医院的品牌信息,含品牌所属公司介绍,北京天坛医院所处行业的品牌地位及优势。
咨询